欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/0890/001
药品名称Ceftriaxon Kabi 2 g Pulver zur Herstellung einer Infusionslösung
活性成分
    • Ceftriaxone 2.0 g
剂型Powder for solution for infusion
上市许可持有人Fresenius Kabi Deutschland GmbH Else-Kröner-Str. 1 61352 Bad Homburg Germany
参考成员国 - 产品名称Germany (DE)
互认成员国 - 产品名称
    • Belgium (BE)
    • Netherlands (NL)
      Ceftriaxone Fresenius Kabi 2 g, poeder voor oplossing voor injectie
    • Austria (AT)
      Ceftriaxon Kabi 2 g Pulver zur Herstellung einer Injektionslösung
    • Greece (GR)
    • Finland (FI)
    • Hungary (HU)
      CEFTRIAXON KABI 2 g por oldatos infúzióhoz
    • Czechia (CZ)
    • Slovakia (SK)
      Ceftriaxon Kabi 2 g
    • Denmark (DK)
    • Luxembourg (LU)
    • Portugal (PT)
    • Sweden (SE)
      Ceftriaxon Kabi 2 g Pulver zur Herstellung einer Infusionslösung
    • Norway (NO)
    • Poland (PL)
    • Lithuania (LT)
      Ceftriaxone Kabi 2 g milteliai injekciniam tirpalui
    • Italy (IT)
    • Iceland (IS)
    • Latvia (LV)
      Ceftriaxone Kabi 2 g pulveris infūziju šķīduma pagatavošanai
许可日期2007/08/28
最近更新日期2024/09/19
药物ATC编码
    • J01DD04 ceftriaxone
申请类型
  • TypeLevel1：Abridged
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase